(NVO) Novo Nordisk - Performance -50.3% in 12m
NVO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
43.82%
#19 in Peer-Group
Rel. Strength
9.62%
#6947 in Stock-Universe
Total Return 12m
-50.27%
#162 in Peer-Group
Total Return 5y
127.94%
#11 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 19.2 |
| P/E Forward | 16.8 |
| High / Low | USD |
|---|---|
| 52 Week High | 139.31 USD |
| 52 Week Low | 58.08 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 41.43 |
| Buy/Sell Signal +-5 | 0.14 |
| Support / Resistance | Levels |
|---|---|
| Support | 68.7, 67.6, 59.7 |
| Resistance | 81.6 |
12m Total Return: NVO (-50.3%) vs XLV (-7.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
2.64% | 125% | 343% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
2.5% | 13.7% | 79.3% | 19.4 | 14.7 | 1.44 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-1.02% | -15.3% | 414% | 64.5 | 36.4 | 1.21 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.06% | 0.79% | 50.7% | 19.5 | 14.7 | 1.44 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-5.43% | 3.38% | 45.1% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-4.81% | -9.99% | 101% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-2.46% | -6.31% | 40.1% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| IPN PA Ipsen |
2.02% | -3.39% | 42.9% | 25.8 | 10.4 | 0.74 | -6.40% | -6.33% |
Performance Comparison: NVO vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for NVO
| Total Return (including Dividends) | NVO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -10.49% | -0.03% | 3.98% |
| 3 Months | 4.36% | -2.07% | 16.24% |
| 12 Months | -50.27% | -7.05% | 12.66% |
| 5 Years | 127.94% | 39.90% | 109.18% |
| Trend Score (consistency of price movement) | NVO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -61.5% | 35.5% | 91.4% |
| 3 Months | 71.3% | -14.5% | 97.5% |
| 12 Months | -92.9% | -79.5% | 46.7% |
| 5 Years | 87.7% | 87.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th10.50 | -10.47% | -13.92% |
| 3 Month | %th31.50 | 6.56% | -10.22% |
| 12 Month | %th19.50 | -46.50% | -55.86% |
| 5 Years | %th95.00 | 62.93% | 8.96% |
FAQs
Does Novo Nordisk (NVO) outperform the market?
No,
over the last 12 months NVO made -50.27%, while its related Sector, the Health Care Sector SPDR (XLV) made -7.05%.
Over the last 3 months NVO made 4.36%, while XLV made -2.07%.
Performance Comparison NVO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NVO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.2% | -14.5% | -21.7% | -63% |
| US NASDAQ 100 | QQQ | -1.3% | -14.7% | -24.1% | -63% |
| German DAX 40 | DAX | -0.9% | -12.4% | -32.3% | -80% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.7% | -15.7% | -23.6% | -70% |
| Hongkong Hang Seng | HSI | -2% | -13% | -43% | -85% |
| India NIFTY 50 | INDA | 0.2% | -11.2% | -21.5% | -47% |
| Brasil Bovespa | EWZ | 4% | -7% | -34.8% | -50% |
NVO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.6% | -13.3% | -26.4% | -75% |
| Consumer Discretionary | XLY | -2.3% | -14.6% | -14.5% | -68% |
| Consumer Staples | XLP | 1% | -10.8% | -20.7% | -58% |
| Energy | XLE | -2.8% | -11.7% | -11.9% | -49% |
| Financial | XLF | -0.3% | -14.8% | -23.4% | -74% |
| Health Care | XLV | -1.1% | -10.5% | -11% | -43% |
| Industrial | XLI | -2% | -16% | -26.7% | -73% |
| Materials | XLB | -1.1% | -14.3% | -20.3% | -53% |
| Real Estate | XLRE | -1.4% | -11.2% | -19.9% | -58% |
| Technology | XLK | -0.8% | -15.9% | -26.3% | -60% |
| Utilities | XLU | -1.5% | -13.4% | -24.6% | -73% |
| Aerospace & Defense | XAR | -3.6% | -20.4% | -42.2% | -100% |
| Biotech | XBI | -6.2% | -16.4% | -15.6% | -39% |
| Homebuilder | XHB | -3.4% | -19.8% | -11.5% | -47% |
| Retail | XRT | -1.6% | -15.6% | -18.4% | -57% |
NVO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.6% | -6.71% | -6.30% | -45% |
| Natural Gas | UNG | -1.7% | -0.5% | 3.5% | -56% |
| Gold | GLD | -0.8% | -9.3% | -38.4% | -88% |
| Silver | SLV | -4.1% | -15.3% | -41% | -74% |
| Copper | CPER | -10.6% | -24% | -39.6% | -73% |
NVO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.1% | -11% | -16.3% | -46% |
| iShares High Yield Corp. Bond | HYG | -0.5% | -11.7% | -18.6% | -59% |